Johnson and Johnson Co. (NYSE: JNJ) is expected to post $22.27 bn in quarterly sales for this fiscal quarter. This is according to the report of Zacks Research. A total of four research analysts have reported estimates regarding the earnings of JNJ stock. The estimates currently range from $21.76 bn to $22.58 bn. In a similar quarter past year, the company reported $18.34 bn in quarterly sales. This hints at a 21.4 percent positive growth rate on a Y-O-Y basis. On 21st July, Wednesday, the JNJ stock is expected to post its upcoming earnings report before the stock market.
JNJ Stock Has Been A Subject Of Several Analyst Reports!
Several analysts have rated the JNJ stock. Morgan Stanley began its coverage of the stock in its research report of 28th May, Friday. Morgan Stanley issued a rating of “overweight” while putting a price objective of $187.00 on the shares of the company. Credit Group issued a rating of “buy” while putting a price objective of $193.00 on the shares of the company in its research report of 7th June, Monday.
One analyst issued a rating of “sell”, while two analysts issued ratings of “hold” and ten issued ratings of “buy” on the shares of the company. The JNJ stock has “Buy” as its average rating and $182.45 as its average price target. The stock began trading on Monday at $161.98. The company has $133.65 as its twelve-month low and $173.65 as its twelve-month high. The company has $461.56 bn as its market capitalization, a 28.62 P/E ratio, a 2.65 P/E/G ratio, and a 0.71 beta. The company has 1.28 as its current ratio, a 1.04 quick ratio, and 0.46 as its ratio between debt and equity.